Discussion
TIA, bleeding, ischemic stroke
MINOR, BLEEDING, TIA, ISCHEMIC STROKE
In this prespecified subgroup analysis of the CHANCE-2 trial, we investigated outcomes among patients with TIA or minor ischemic stroke with ticagrelor-aspirin or clopidogrel-aspirin based on background Various studies have reported that It is well established that patients carrying LOF The absolute risk of severe or moderate bleeding was low in both treatment groups, and the risk among those treated with ticagrelor-aspirin was not significantly greater than that among those treated with clopidogrel-aspirin regardless of phenotypes for 